학술논문
Antitumor activity of MEDI3726 (ADCT-401), a pyrrolobenzodiazepine antibody-drug conjugate targeting PSMA, in preclinical models of prostate cancer
Document Type
Article
Author
Williams, D.G.; Tyrer, P.; D'Hooge, F.; Bertelli, F.; Corbett, S.; Adams, L.; Howard, P.W.; Hartley, J.A.; Reinert, H.W.; Corey, E.; Liu, H.; Kim, S.; Bander, N.H.; Cho, S.; Monks, N.R.; Fleming, R.; Vashisht, K.; Dimasi, N.; King, W.; Dacosta, K.; Tammali, R.; Schifferli, K.; Strout, P.; Korade, M.; Hinrichs, M.J.M.; Coats, S.; Tice, D.A.; Herbst, R.; Zammarchi, F.; Havenith, C.E.G.; Dissanayake, S.; Britten, C.E.; Chivers, S.; Van Berkel, P.H.
Source
In: Molecular Cancer Therapeutics . (Molecular Cancer Therapeutics, October 2018, 17(10):2176-2186)
Subject
Language
English
ISSN
15388514
15357163
15357163